II. Pathophysiology
-
Lymphoproliferative Malignancy
- Proliferation of plasma cells and Lymphocytes
- Similar to Multiple Myeloma
- Produces a large monoclonal IgM Protein
III. Epidemiology
- Older men more frequently affected
- Hereditary component
IV. Symptoms
- Weakness
- Fatigue
- Oronasal bleeding
- Blurred Vision or Decreased Visual Acuity (33%)
- No Bone pain
- Contrast with Multiple Myeloma
- Hyperviscosity results in neurologic symptoms
- Sudden Deafness
- Progressive spinal muscular atrophy
V. Signs
- Pallor
- Splenomegaly
- Hepatomegaly
- Peripheral Lymphadenopathy
-
Retinal lesions
- Retinal Hemorrhage
- Retinal Exudate
- Venous congestion
- Peripheral Neuropathy
- Pulmonary Disease
- Infiltrates or Pleural Effusion
VI. Labs
-
Complete Blood Count
- Normocytic normochromic Anemia
-
Peripheral Smear
- Rouleau formation
- Erythrocyte Sedimentation Rate markedly elevated
-
Bone Marrow Biopsy
- Hypocellular
- Extensive Infiltrations by lymphoid and plasma cells
- Increased Mast Cell numbers
-
Immunoelectrophoresis
- Monoclonal IgM Protein >3 g/dl
VII. Differential Diagnosis
VIII. Management
- Suppression of Lymphocyte and Plasma Cell proliferation
- Chlorambucil
- Cyclophosphamide
- Combination chemotherapeutic regimens
- Hyperviscosity
- Plasmapheresis with cell separator
IX. Prognosis
- Five Year median survival after diagnosis